- Home
- Activity-based Biochemical Screening/Profiling Assay Services
- ADP-Glo™ Kinase Assay QuickScout™ Lipid Panel
ADP-Glo™ Kinase Assay QuickScout™ Lipid Panel
We determine the potency and selectivity of your compounds against lipid kinases using ADP-Glo™ technology where the ADP generated, as a side product of phosphorylation, is converted to ATP and detected as luminescence (RLU value). All protein kinases deployed in our assays are produced by Carna and quality controlled to guarantee high quality data is delivered to you. The ATP concentration of our lipid kinase assays is set at the approximate Km for each kinase.
The IC50s and/or the inhibition ratio is calculated for your compounds against the lipid kinase targets you chose utilizing the ADP-Glo™ assay platform. Please check our service schedule and assay conditions, and complete our Application Form specific for ADP-Glo™ Assays. Please submit it as an e-mail attachment to info@carnabio.com.
For Mobility Shift Assay/IMAP™ Profiling Service requests, please start from here.
| Target Name | Group |
Source (Carna Catalog No.) |
| DGKα(DGKA) | Lipid | 12-401-20N |
| DGKβ(DGKB) | Lipid | 12-402-20N |
| DGKγ(DGKG) | Lipid | 12-403-20N |
| DGKδ(DGKD) | Lipid | 12-404-20N |
| DGKε(DGKE) | Lipid | 12-415-20N |
| DGKζ(DGKZ) | Lipid | 12-410-20N |
| DGKη(DGKH) | Lipid | 12-406-20N |
| DGKθ(DGKQ) | Lipid | 12-409-20N |
| DGKι(DGKI) | Lipid | 12-407-20N |
| DGKκ(DGKK) | Lipid | 12-408-20N |
| PIK3CA[E542K]/PIK3R1 | Lipid | 11-413-20N |
| PIK3CA[E545K]/PIK3R1 | Lipid | 11-414-20N |
| PIK3CA[H1047R]/PIK3R1 | Lipid | 11-415-20N |
| PIK3CA[P539R]/PIK3R1 | Lipid | 11-412-20N |
| PIK3CA[R88Q]/PIK3R1 | Lipid | 11-411-20N |
| PIK3CA／PIK3R1 | Lipid | 11-401-20N |
| PIK3CB／PIK3R1 | Lipid | 11-402-20N |
| PIK3CD／PIK3R1 | Lipid | 11-403-20N |
| PIKFYVE(PIP5K3) | Lipid | 11-118 |
| PIP4K2A | Lipid | 11-115 |
| PIP4K2B | Lipid | 11-116 |
| PIP5K1A | Lipid | 11-111 |
| PIP5K1B | Lipid | 11-112 |
| PIP5K1C | Lipid | 11-113 |
| PIP5KL1 | Lipid | 11-114 |
Service Schedule
| March 2023 | ||||||
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 | |
| April 2023 | ||||||
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 | ||||||
Detailed Assay Conditions
for Each Kinase
Check this out & more in our Kinase Profiling Book!
